Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;37(5):2017-2033.
doi: 10.1007/s12325-020-01346-6. Epub 2020 Apr 20.

Psoriasis and Cardiovascular Risk: A Comprehensive Review

Walter Masson  1   2 , Martín Lobo  3 , Graciela Molinero  3
Affiliations
Review

Psoriasis and Cardiovascular Risk: A Comprehensive Review

Walter Masson et al. Adv Ther. 2020 May.

Abstract

Psoriasis is a systemic inflammatory disorder that involves complex pathogenic interactions between the innate and adaptive immune systems. Individuals with psoriasis have an increased risk of developing other chronic health diseases such cardiovascular disorders. The high incidence of cardiovascular events in the population with psoriasis could be explained by several mechanisms. The high prevalence of traditional cardiovascular risk factors and metabolic abnormalities contributes to the high cardiovascular burden in patients with psoriasis. Likewise, the presence of systemic inflammation in combination with metabolic abnormalities may act in a synergistic manner to increase cardiovascular risk in these patients. This review focused on epidemiologic and clinical evidence linking psoriasis to cardiovascular risk factors and cardiovascular disease. We described the possible pathophysiological mechanisms that justify this association and analyzed the best way to stratify the cardiovascular risk in patients with psoriasis. We also described the usefulness of the therapies frequently used in cardiovascular prevention and analyzed the impact of the specific psoriasis medication on cardiovascular risk factors or major atherosclerotic events. Knowledge of the application of different cardiovascular prevention strategies could mean an advantage in performing the difficult task of estimating cardiovascular risk and treating cardiovascular risk factors in this particular group of patients.

Keywords: Cardiovascular disease; Cardiovascular risk factors; Cardiovascular risk stratification; Psoriasis; Statins.

PubMed Disclaimer

References

    1. Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983–994. doi: 10.1016/S0140-6736(14)61909-7. - DOI - PubMed
    1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496–509. doi: 10.1056/NEJMra0804595. - DOI - PubMed
    1. McDonald CJ, Calabresi P. Occlusive vascular disease in psoriatic patients. N Engl J Med. 1973;288:912. doi: 10.1056/NEJM197304262881715. - DOI - PubMed
    1. Caiazzo G, Fabbrocini G, Di Caprio R, et al. Psoriasis, cardiovascular events, and biologics: lights and shadows. Front Immunol. 2018;9:1668. doi: 10.3389/fimmu.2018.01668. - DOI - PMC - PubMed
    1. Puig Lluís. Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci. 2018;19(1):58. doi: 10.3390/ijms19010058. - DOI - PMC - PubMed